Use of a DPP-IV inhibitor to reduce hypoglycemic events

Details for Australian Patent Application No. 2006292377 (hide)

Owner Novartis AG

Inventors Balkan, Bork; Hughes, Thomas Edward; Holmes, David Grenville; Villhauer, Edwin Bernard

Agent Davies Collison Cave

Pub. Number AU-B-2006292377

PCT Pub. Number WO2007/035665

Priority 60/786,755 28.03.06 US; 60/718,856 20.09.05 US

Filing date 18 September 2006

Wipo publication date 29 March 2007

Acceptance publication date 3 March 2011

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/035665 Priority application(s): WO2007/035665

3 March 2011 Application Accepted

  Published as AU-B-2006292377

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292394-Systems and methods for enrichment of analytes

2006292362-Methods for genetic control of insect infestations in plants and compositions thereof